Literature DB >> 11440982

Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice.

X Wang1, H Osinska, R Klevitsky, A M Gerdes, M Nieman, J Lorenz, T Hewett, J Robbins.   

Abstract

Upregulation of alphaB-crystallin (CryAB), a small heat shock protein, is associated with a variety of diseases, including the desmin-related myopathies. CryAB, which binds to both desmin and cytoplasmic actin, may participate as a chaperone in intermediate filament formation and maintenance, but the physiological consequences of CryAB upregulation are unknown. A mutation in CryAB, R120G, has been linked to a familial desminopathy. However, it is unclear whether the mutation is directly causative. We created multiple transgenic mouse lines that overexpressed either murine wild-type CryAB or the R120G mutation in cardiomyocytes. Overexpression of wild-type CryAB was relatively benign, with no increases in mortality and no induction of desmin-related cardiomyopathy even in a line in which CryAB mRNA expression was increased approximately 104-fold and the protein level increased by 11-fold. In contrast, lines expressing the R120G mutation were compromised, with a high-expressing line exhibiting 100% mortality by early adulthood. Modest expression levels resulted in a phenotype that was strikingly similar to that observed for the desmin-related cardiomyopathies. The desmin filaments in the cardiomyocytes were overtly affected, myofibril alignment was significantly impaired, and a hypertrophic response occurred at both the molecular and cellular levels. The data show that the R120G mutation causes a desminopathy, is dominant negative, and results in cardiac hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440982     DOI: 10.1161/hh1301.092688

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  139 in total

1.  On genetics of dilated cardiomyopathy and transgenic models: all is not crystal clear in myopathic hearts.

Authors:  A J Marian
Journal:  Circ Res       Date:  2001-07-06       Impact factor: 17.367

Review 2.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  Untangle a Broken Heart via Janus Kinase 1.

Authors:  Chen Gao; Yibin Wang
Journal:  Circ Res       Date:  2017-09-01       Impact factor: 17.367

4.  COP9 signalosome controls the degradation of cytosolic misfolded proteins and protects against cardiac proteotoxicity.

Authors:  Huabo Su; Jie Li; Hanming Zhang; Wenxia Ma; Ning Wei; Jinbao Liu; Xuejun Wang
Journal:  Circ Res       Date:  2015-09-17       Impact factor: 17.367

Review 5.  The interplay between autophagy and the ubiquitin-proteasome system in cardiac proteotoxicity.

Authors:  Changhua Wang; Xuejun Wang
Journal:  Biochim Biophys Acta       Date:  2014-08-01

6.  Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes.

Authors:  Manish K Gupta; James Gulick; Ruijie Liu; Xuejun Wang; Jeffery D Molkentin; Jeffrey Robbins
Journal:  Circ Res       Date:  2014-08-05       Impact factor: 17.367

Review 7.  Priming the proteasome by protein kinase G: a novel cardioprotective mechanism of sildenafil.

Authors:  Hanming Zhang; Xuejun Wang
Journal:  Future Cardiol       Date:  2015-03

8.  Differential protein acetylation assists import of excess SOD2 into mitochondria and mediates SOD2 aggregation associated with cardiac hypertrophy in the murine SOD2-tg heart.

Authors:  Liwen Zhang; Chwen-Lih Chen; Patrick T Kang; Zhicheng Jin; Yeong-Renn Chen
Journal:  Free Radic Biol Med       Date:  2017-04-20       Impact factor: 7.376

9.  Biochemical and mechanical dysfunction in a mouse model of desmin-related myopathy.

Authors:  Alina Maloyan; Hanna Osinska; Jan Lammerding; Richard T Lee; Oscar H Cingolani; David A Kass; John N Lorenz; Jeffrey Robbins
Journal:  Circ Res       Date:  2009-03-19       Impact factor: 17.367

Review 10.  Breaking down protein degradation mechanisms in cardiac muscle.

Authors:  Robert C Lyon; Stephan Lange; Farah Sheikh
Journal:  Trends Mol Med       Date:  2013-02-27       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.